Next Article in Journal
A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
Next Article in Special Issue
Neonatal Screening on Tandem Mass Spectrometry as a Powerful Tool for the Reassessment of the Prevalence of Underestimated Diseases in Newborns and Their Family Members: A Focus on Short Chain Acyl-CoA Dehydrogenase Deficiency
Previous Article in Journal
Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA
Previous Article in Special Issue
Screening Pathways through China, the Asia Pacific Region, the World
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
IJNS
Volume 5
Issue 4
10.3390/ijns5040040
IJNS-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service

by
Julia C. van Campen
1,*,†,‡,
Elizabeth S. A. Sollars
1,†,
Rebecca C. Thomas
1,†,
Clare M. Bartlett
1,
Antonio Milano
1,§,
Matthew D. Parker
1,‖,
Jennifer Dawe
1,
Peter R. Winship
1,
Gerrard Peck
1,
Darren Grafham
1,
Richard J. Kirk
1,
James R. Bonham
2,
Anne C. Goodeve
1,3 and
Ann Dalton
1,*
1
Sheffield Diagnostic Genetics Service (SDGS), Sheffield Children’s NHS Foundation Trust, Western Bank, Sheffield S10 2TH, UK
2
Division of Pharmacy, Diagnostics and Genetics, Sheffield Children’s NHS Foundation Trust, Western Bank, Sheffield S10 2TH, UK
3
Department of Infection, Immunity & Cardiovascular Disease, Faculty of Medicine, Dentistry & Health, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
Present address: Genetics Centre, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK.
§
Present address: Pathology Department, Sidra Medicine, Main Hospital, H2M-24091, PO Box 26999, Doha, Qatar.
‖
Present address: Sheffield Bioinformatics Core, Sheffield Biomedical Research Centre, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
Int. J. Neonatal Screen. 2019, 5(4), 40; https://doi.org/10.3390/ijns5040040
Received: 1 August 2019 / Revised: 14 October 2019 / Accepted: 24 October 2019 / Published: 5 November 2019
(This article belongs to the Special Issue Selected Papers from 10th ISNS International Symposium/11th Asia Pacific Regional Meeting)
View Full-Text Download PDF
Browse Figures

Abstract

Next generation DNA sequencing (NGS) has the potential to improve the diagnostic and prognostic utility of newborn screening programmes. This study assesses the feasibility of automating NGS on dried blood spot (DBS) DNA in a United Kingdom National Health Service (UK NHS) laboratory. An NGS panel targeting the entire coding sequence of five genes relevant to disorders currently screened for in newborns in the UK was validated on DBS DNA. An automated process for DNA extraction, NGS and bioinformatics analysis was developed. The process was tested on DBS to determine feasibility, turnaround time and cost. The analytical sensitivity of the assay was 100% and analytical specificity was 99.96%, with a mean 99.5% concordance of variant calls between DBS and venous blood samples in regions with ≥30× coverage (96.8% across all regions; all variant calls were single nucleotide variants (SNVs), with indel performance not assessed). The pipeline enabled processing of up to 1000 samples a week with a turnaround time of four days from receipt of sample to reporting. This study concluded that it is feasible to automate targeted NGS on routine DBS samples in a UK NHS laboratory setting, but it may not currently be cost effective as a first line test. View Full-Text
Keywords: newborn screening; next generation sequencing; automation newborn screening; next generation sequencing; automation
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

SciFeed

Share and Cite

MDPI and ACS Style

van Campen, J.C.; Sollars, E.S.A.; Thomas, R.C.; Bartlett, C.M.; Milano, A.; Parker, M.D.; Dawe, J.; Winship, P.R.; Peck, G.; Grafham, D.; Kirk, R.J.; Bonham, J.R.; Goodeve, A.C.; Dalton, A. Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service. Int. J. Neonatal Screen. 2019, 5, 40. https://doi.org/10.3390/ijns5040040

AMA Style

van Campen JC, Sollars ESA, Thomas RC, Bartlett CM, Milano A, Parker MD, Dawe J, Winship PR, Peck G, Grafham D, Kirk RJ, Bonham JR, Goodeve AC, Dalton A. Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service. International Journal of Neonatal Screening. 2019; 5(4):40. https://doi.org/10.3390/ijns5040040

Chicago/Turabian Style

van Campen, Julia C., Elizabeth S.A. Sollars, Rebecca C. Thomas, Clare M. Bartlett, Antonio Milano, Matthew D. Parker, Jennifer Dawe, Peter R. Winship, Gerrard Peck, Darren Grafham, Richard J. Kirk, James R. Bonham, Anne C. Goodeve, and Ann Dalton. 2019. "Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service" International Journal of Neonatal Screening 5, no. 4: 40. https://doi.org/10.3390/ijns5040040

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop